[go: up one dir, main page]

NZ512402A - Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale - Google Patents

Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale

Info

Publication number
NZ512402A
NZ512402A NZ51240201A NZ51240201A NZ512402A NZ 512402 A NZ512402 A NZ 512402A NZ 51240201 A NZ51240201 A NZ 51240201A NZ 51240201 A NZ51240201 A NZ 51240201A NZ 512402 A NZ512402 A NZ 512402A
Authority
NZ
New Zealand
Prior art keywords
vitamin
tinnitus
treatment
amino acids
smooth muscle
Prior art date
Application number
NZ51240201A
Inventor
Supplied Not
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Priority to NZ51240201A priority Critical patent/NZ512402A/en
Publication of NZ512402A publication Critical patent/NZ512402A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The use of biochemical substances comprising vitamins, amino acids and trace elements for a composition for the prevention and/or treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body. Such conditions include high blood pressure, asthma, glaucoma and tinnitus.
NZ51240201A 2001-06-15 2001-06-15 Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale NZ512402A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ51240201A NZ512402A (en) 2001-06-15 2001-06-15 Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ51240201A NZ512402A (en) 2001-06-15 2001-06-15 Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale

Publications (1)

Publication Number Publication Date
NZ512402A true NZ512402A (en) 2003-02-28

Family

ID=19928516

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ51240201A NZ512402A (en) 2001-06-15 2001-06-15 Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale

Country Status (1)

Country Link
NZ (1) NZ512402A (en)

Similar Documents

Publication Publication Date Title
CA2350713A1 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
UA90893C2 (en) Oral dosage forms of gemcitabine derivatives
CY1108138T1 (en) USE OF LUPINOCONGLUTINE FOR TREATMENT OF DIABETES TYPE II
EP1393734A4 (en) Drugs for intestinal diseases
CA2412789A1 (en) Compositions for improving mental concentration
WO2004058268A3 (en) Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
WO2004006911A3 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
NZ512402A (en) Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
SI1581239T1 (en) Early use of an extract of red vine leaves
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
DK1497250T3 (en) Hyperforin derivatives, their use and compositions containing them
AU2001262773A1 (en) Novel oligonucleotide compounds having pyrrolizine derivatives, processes fro preparing them, compositions containing them and uses thereof in treatment, diagnosis and analysis of gene-related diseases
Korhonen Dietary treatment of elevated blood pressure
HUP0402526A3 (en) Hydroxylamine derivatives useful in the treatment of vascular diseases, pharmaceutical compositions containing them and use thereof
WO2004039978A3 (en) Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases
WO2002072527A3 (en) 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof
ITRM20030213A0 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PSYCHIC DISEASES AND DISORDERS RELATED TO THEM.
SG106614A1 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
RU2002127274A (en) USE OF THE PREPARATION VETOM-7048 FOR THE FIRST TIME AS A MEDICINAL PRODUCT IN THE TREATMENT OF BRAIN ATROPHY, BRAIN HYDROCEPHALIA

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)